Compare AMETEK, Inc. (AME) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AMETEK, Inc. vs Heron Therapeutics Inc — how do they compare? AMETEK, Inc. trades at $255.78 (market cap $58.76B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: AMETEK, Inc. is far larger — about 955.9× Heron Therapeutics Inc's market cap, and AMETEK, Inc. pays a 0.53% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| AME | HRTX | |
|---|---|---|
Market Cap | $58.76B | $61.47M |
Sector | Industrials | Health |
52-Week High | $256.30 | $1.49 |
52-Week Low | $179.28 | $0.32 |
Enterprise Value | $60.30B | $168.21M |
Dividend Yield | 0.53% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AMETEK, Inc.
Ametek is a diversified industrial conglomerate with over $6 billion in sales. The firm operates through an electronic instruments group and an electromechanical group. EIG designs and manufactures differentiated and advanced instruments for the process, aerospace, power, and industrial end markets. EMG is a focused, niche supplier of highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects, among other products. About half of the firm's sales are made in the United States. The firm's asset-light strategy in place for nearly two decades emphasizes growth through acquisitions, new product development through research and development, driving operational efficiencies, and global and market expansion.
Read more on AME →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
